ArticlePharmaceutics2024

Development, Characterization, and Evaluation of Potential Systemic Toxicity of a Novel Oral Melatonin Formulation.

Catalina N Cheaburu-Yilmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.